Hepatocyte growth factor enhances proteolysis and invasiveness of human nasopharyngeal cancer cells through activation of PI3K and JNK

[1]  Quan-guang Zhang,et al.  Critical role of PTEN in the coupling between PI3K/Akt and JNK1/2 signaling in ischemic brain injury , 2007, FEBS letters.

[2]  J. Nishikawa,et al.  AIB1 promotes DNA replication by JNK repression and AKT activation during cellular stress. , 2006, Journal of biochemistry.

[3]  D. Schlaepfer,et al.  Angiopoietin 2 induces glioma cell invasion by stimulating matrix metalloprotease 2 expression through the alphavbeta1 integrin and focal adhesion kinase signaling pathway. , 2006, Cancer research.

[4]  D. Maysinger,et al.  Cross-talk between phosphatidylinositol 3-kinase/AKT and c-jun NH2-terminal kinase mediates survival of isolated human islets. , 2004, Endocrinology.

[5]  Y. Kwong,et al.  Clinicopathologic significance of plasma matrix metalloproteinase-2 and -9 levels in patients with undifferentiated nasopharyngeal carcinoma. , 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[6]  S. Akira,et al.  Elucidation of the c-Jun N-Terminal Kinase Pathway Mediated by Epstein-Barr Virus-Encoded Latent Membrane Protein 1 , 2004, Molecular and Cellular Biology.

[7]  T. Yoshizaki,et al.  Matrix metalloproteinase 9 is induced by the Epstein–Barr virus BZLF1 transactivator , 1999, Clinical & Experimental Metastasis.

[8]  J. Pignon,et al.  Nasopharyngeal carcinomas: an update. , 2003, European journal of cancer.

[9]  B. Bauvois,et al.  Matrix Metalloproteinase-9 Silencing by RNA Interference Triggers the Migratory-adhesive Switch in Ewing's Sarcoma Cells* , 2003, Journal of Biological Chemistry.

[10]  G. Taraboletti,et al.  Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation. , 2003, Cancer research.

[11]  Ken Jacobson,et al.  JNK phosphorylates paxillin and regulates cell migration , 2003, Nature.

[12]  P. Comoglio,et al.  Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. , 2003, Cancer cell.

[13]  S. Tsao,et al.  The significance of LMP1 expression in nasopharyngeal carcinoma. , 2002, Seminars in cancer biology.

[14]  P. Accornero,et al.  K252a inhibits the oncogenic properties of Met, the HGF receptor , 2002, Oncogene.

[15]  B. Teh,et al.  Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma. , 2002, Cancer research.

[16]  C. Van Waes,et al.  Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma. , 2001, Cancer research.

[17]  T. Yoshizaki,et al.  Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma. , 2001, The American journal of pathology.

[18]  P. Bork,et al.  The p150-Spir protein provides a link between c-Jun N-terminal kinase function and actin reorganization , 2000, Current Biology.

[19]  James Varani,et al.  Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor‐stimulated human epidermal keratinocytes , 1999, Journal of cellular physiology.

[20]  Hiroki Sato,et al.  Matrix Metalloproteinase 9 Expression Is Induced by Epstein-Barr Virus Latent Membrane Protein 1 C-Terminal Activation Regions 1 and 2 , 1999, Journal of Virology.

[21]  R. Herrera.  Modulation of hepatocyte growth factor-induced scattering of HT29 colon carcinoma cells. Involvement of the MAPK pathway. , 1998, Journal of cell science.

[22]  E. Lengyel,et al.  Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades , 1997, Oncogene.

[23]  H. K. Sluss,et al.  Selective interaction of JNK protein kinase isoforms with transcription factors. , 1996, The EMBO journal.

[24]  L. Coussens,et al.  Matrix metalloproteinases and the development of cancer. , 1996, Chemistry & biology.

[25]  M. Karin.  The Regulation of AP-1 Activity by Mitogen-activated Protein Kinases (*) , 1995, The Journal of Biological Chemistry.

[26]  Z. Sizhong,et al.  Cytogenetic studies on an epithelial cell line derived from poorly differentiated nasopharyngeal carcinoma , 1983, International journal of cancer.